BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Viventia Biotech Inc. 

5060 Spectrum Way
Suite 405
Mississauga  Ontario  L4W 5N5  Canada
Phone: 905-361-8686 Fax: 905-361-2673


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Viventia Biotech Inc. (VBI.TO) to Explore Strategic Alternatives; Reports Positive Pivotal Phase III Interim Efficacy Data 1/29/2008 7:25:35 AM    More...
Viventia Biotech Inc. (VBI.TO) Initiates Patient Treatment for Phase I Trial of VB6-845 Anti-Cancer Antibody 6/11/2007 11:03:21 AM    More...
Viventia Biotech Inc. (VBI.TO) Reports Final Vicinium(TM) Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting 5/25/2007 10:11:13 AM    More...
Viventia Biotech Inc. (VBI.TO) Generates Novel Human Anti-Cancer Antibody, VB1-050, and Identifies its Novel Target 4/18/2007 12:36:57 PM    More...
Viventia Biotech Inc. (VBI.TO) Reports Synergystic Effect of its Proxinium(TM) Antibody in Combinaton with Chemotherapy and Radiation 4/18/2007 12:33:00 PM    More...
Viventia Biotech Inc. (VBI.TO) Initiates Patient Treatment for Vicinium(TM) Phase II Bladder Cancer Trial 4/3/2007 11:35:40 AM    More...
Viventia Biotech Inc. (VBI.TO) Provides Update On Cancer Antibody Clinical Development Programs 2/14/2007 2:30:52 PM    More...
CODA Genomics, Inc. Announces Collaboration Expansion With Viventia Biotech Inc. (VBI.TO) 12/20/2006 4:22:05 PM    More...
Viventia Biotech Inc. (VBI.TO) And Dowpharma (DOW)(SM) Announce A Multi-Product Commercial License Agreement Using Pfenex Expression Technology(TM) From Dowpharma (DOW) 2/14/2006 2:31:16 PM    More...
Viventia Biotech Inc. (VBI.TO) Announces Voting Results Of The Shareholders Meeting And The Vlosing Of Transaction To Become A Private Company 12/27/2005 12:46:19 PM    More...
1234